Deriving Ligand Orientation in Weak Protein-Ligand Complexes by DEEP-STD NMR Spectroscopy in the Absence of Protein Chemical-Shift Assignment.
DEEP-STD
NMR spectroscopy
TEMPOL
mixed molecular dynamics
Journal
Chembiochem : a European journal of chemical biology
ISSN: 1439-7633
Titre abrégé: Chembiochem
Pays: Germany
ID NLM: 100937360
Informations de publication
Date de publication:
01 02 2019
01 02 2019
Historique:
received:
21
09
2018
pubmed:
1
11
2018
medline:
28
11
2019
entrez:
1
11
2018
Statut:
ppublish
Résumé
Differential epitope mapping saturation transfer difference (DEEP-STD) NMR spectroscopy is a recently developed powerful approach for elucidating the structure and pharmacophore of weak protein-ligand interactions, as it reports key information on the orientation of the ligand and the architecture of the binding pocket. The method relies on selective saturation of protein residues in the binding site and the generation of a differential epitope map by observing the ligand, which depicts the nature of the protein residues making contact with the ligand in the bound state. Selective saturation requires knowledge of the chemical-shift assignment of the protein residues, which can be obtained either experimentally by NMR spectroscopy or predicted from 3D structures. Herein, we propose a simple experimental procedure to expand the DEEP-STD NMR methodology to protein-ligand cases in which the spectral assignment of the protein is not available. This is achieved by experimentally identifying the chemical shifts of the residues present in binding hot-spots on the surface of the receptor protein by using 2D NMR experiments combined with a paramagnetic probe.
Identifiants
pubmed: 30379391
doi: 10.1002/cbic.201800568
pmc: PMC6468252
doi:
Substances chimiques
Cyclic N-Oxides
0
Epitopes
0
Ligands
0
Proteins
0
Spin Labels
0
tempol
U78ZX2F65X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
340-344Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/F/00044452
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P008895/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/J004529/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R012490/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/P010660/1
Pays : United Kingdom
Informations de copyright
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
Références
J Chem Inf Model. 2012 Aug 27;52(8):2236-44
pubmed: 22770357
J Am Chem Soc. 2002 Jan 23;124(3):372-3
pubmed: 11792196
J Biomol NMR. 1999 Oct;15(2):125-33
pubmed: 10605086
J Med Chem. 2009 Apr 23;52(8):2363-71
pubmed: 19296650
J Am Chem Soc. 2001 Jun 27;123(25):6108-17
pubmed: 11414845
J Magn Reson. 2004 May;168(1):36-45
pubmed: 15082247
Drug Discov Today. 2012 May;17(9-10):505-13
pubmed: 22210119
J Chem Inf Model. 2013 Feb 25;53(2):391-402
pubmed: 23327200
Biophys Chem. 2008 Oct;137(2-3):71-5
pubmed: 18678440
Eur Biophys J. 2011 Dec;40(12):1357-69
pubmed: 21947507
Biochim Biophys Acta Proteins Proteom. 2017 Feb;1865(2):201-207
pubmed: 27890678
Biochemistry. 1990 Oct 30;29(43):10041-8
pubmed: 2176860
Biopolymers. 2016 Jan;105(1):21-34
pubmed: 26385317
Chem Rev. 2009 Sep;109(9):4108-39
pubmed: 19522502
Chembiochem. 2019 Feb 1;20(3):340-344
pubmed: 30379391
Angew Chem Int Ed Engl. 1999 Jun 14;38(12):1784-1788
pubmed: 29711196
Nat Commun. 2015 Jul 08;6:7624
pubmed: 26154892
J Biomol NMR. 2011 May;50(1):43-57
pubmed: 21448735
Angew Chem Int Ed Engl. 2017 Nov 27;56(48):15289-15293
pubmed: 28977722
Protein Sci. 2001 Aug;10(8):1498-507
pubmed: 11468346
J Mol Biol. 2003 Sep 12;332(2):437-47
pubmed: 12948493